Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Boehringer Ingelheim Vetmedica Gmbh patents (2016 archive)


Recent patent applications related to Boehringer Ingelheim Vetmedica Gmbh. Boehringer Ingelheim Vetmedica Gmbh is listed as an Agent/Assignee. Note: Boehringer Ingelheim Vetmedica Gmbh may have other listings under different names/spellings. We're not affiliated with Boehringer Ingelheim Vetmedica Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boehringer Ingelheim Vetmedica Gmbh-related inventors


Connecting and container system

A container system having at least two containers, preferably bottles, each of which has a removal opening, preferably closed off by a septum in each case, wherein the containers have, on a side remote from the respective removal opening, particularly on the bottom of the respective bottle, a connecting arrangements for providing a fluidic connection between the containers, and/or having at least one container which forms a removal opening. The container has, on a side remote from the removal opening, a removable, cap-shaped cover which forms a holding device, for a region of the container forming the removal opening, so that the cover can be used as a support foot for the container when it is held by the holding device in the region forming the removal opening.. ... Boehringer Ingelheim Vetmedica Gmbh

Connecting and container system

A connecting system for providing a fluidic connection, preferably between containers, wherein the connecting system has at least two connecting arrangements configured to provide the fluidic connection, namely a first connecting arrangement and a second connecting arrangement, each of which is fluidically sealed in an initial state, wherein the first connecting arrangement has, in particular, a film-shaped, brittle and/or unstable opening region, is deformable outside the opening region and is configured such that deformation causes the first connecting arrangement to open in the opening region.. . ... Boehringer Ingelheim Vetmedica Gmbh

Immunogenic compositions comprising lawsonia intracellularis

The present invention provides combination vaccines that comprise an immunological agent effective for reducing the incidence of or lessening the severity of ppe caused by l. Intracellularis, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine. ... Boehringer Ingelheim Vetmedica Gmbh

Use of dihydroimidazolones for the treatment of dogs

The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1h-imidazol-2-one] (awd 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.. . ... Boehringer Ingelheim Vetmedica Gmbh

H5 proteins of h5n1 influenza virus for use as a medicament

The present invention is based on the surprising finding that h5 protein of clade 1 h5n1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with h5n1 ha. In one aspect, the invention is thus directed to h5 protein of clade 1 h5n1 virus for use in a method of treating or preventing infections with h5n1 virus of a different clade, wherein the h5n1 virus of a different clade comprises a particular polynucleotide and/or h5 protein.. ... Boehringer Ingelheim Vetmedica Gmbh

Treatment of metabolic disorders in canine animals

The present invention relates to one or more sglt2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder in a canine animal, preferably wherein the metabolic disorder is one or more selected from the group consisting of: ketoacidosis, pre-diabetes, insulin dependent diabetes mellitus, insulin resistance diabetes, insulin resistance, obesity, hyperglycemia, hyperglycemia induced cataract formation, impaired glucose tolerance, hyperinsulinemia, dyslipidemia, dysadipokinemia, subclinical inflammation, systemic inflammation, low grade systemic inflammation, hepatic lipidosis, inflammation of the pancreas, metabolic disorder consequences, such as hypertension, renal dysfunction and/or muscoskeletal disorders, and/or syndrome x (metabolic syndrome), wherein preferably the development of hyperglycemia induced cataract formation is prevented or remission is achieved and/or wherein preferably the development of metabolic disorder consequences, such as hypertension, renal dysfunction and/or muscoskeletal disorders, is prevented or progression is slowed or remission is achieved.. . ... Boehringer Ingelheim Vetmedica Gmbh

1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal

A method of treating a metabolic disorder or metabolic disease includes administering a pharmaceutically effective dose of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine, or a pharmaceutically acceptable salt thereof, to a predominantly carnivorous non-human animal in need thereof such that the severity of one or more clinical symptoms of the metabolic disorder or metabolic disease is reduced.. . ... Boehringer Ingelheim Vetmedica Gmbh

Prrs virus variant, european prrs virus cdna clone, and uses thereof

The present invention belongs to the field of animal health and provides means to study porcine reproductive and respiratory syndrome (prrs), a viral disease affecting swine, and for the development of vaccines, therapeutics and diagnostics for the prophylaxis, treatment and diagnosis of prrs. In a first consideration, the invention relates to a new prrs virus variant, and, in a second consideration, to a nucleic acid sequence which comprises the genome of an infectious genotype i (eu) prrs virus clone. ... Boehringer Ingelheim Vetmedica Gmbh

Marker system, in particular for baculovirus-expressed subunit antigens

The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.. ... Boehringer Ingelheim Vetmedica Gmbh

Bivalent swine influenza virus vaccine

The present invention relates to an immunogenic composition comprising: a) a modified live h3 virus of swine influenza, and b) a modified live h1 virus of swine influenza. Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. ... Boehringer Ingelheim Vetmedica Gmbh

Schmallenberg virus (sbv) vaccine, methods of production, and uses thereof

The present invention relates to the field of vaccines and medicaments for the prophylaxis and treatment of infectious diseases in ruminants. In particular, it relates to inactivated schmallenberg virus (sbv) useful as vaccine or medicament for preventing or treating viremia, the transmission and clinical symptoms, in particular malformations in newborn ruminants such as cattle, sheep and goats, induced by sbv.. ... Boehringer Ingelheim Vetmedica Gmbh

Orf2 protein of pcv2 subtype a (pcv2a) for use in cross-protection

Vaccination methods to control pcv2 infection with different pcv2 subtypes are disclosed. Specifically, a pcv2 subtype a (pcv2a) orf2 proteins or immunogenic compositions comprising a pcv2a orf2 protein are used in a method for the treatment or prevention of an infection with pcv2 of a different subtype, the reduction, prevention or treatment of clinical signs caused by an infection with pcv2 of a different subtype, or the prevention or treatment of a disease caused by an infection with pcv2 of a different subtype.. ... Boehringer Ingelheim Vetmedica Gmbh

Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs

The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (pcv2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a pcv2 infection. ... Boehringer Ingelheim Vetmedica Gmbh

Method of making a mycoplasma vaccine

The present invention relates to a method for the preparation of an immunogenic composition for the treatment and/or prophylaxis of mycoplasma infections in a subject comprising the cultivation of mycoplasma bacteria in a serum-reduced or swine serum-free, eukaryotic cell system; obtaining an antigen of the mycoplasma bacteria; and addition of a pharmaceutically acceptable carrier. Further, the present invention relates to the immunogenic composition obtainable by said method and a method for immunizing a subject comprising the administration of said immunogenic composition to a subject.. ... Boehringer Ingelheim Vetmedica Gmbh

05/05/16 / #20160126151

Method for producing a plurality of measurement regions on a chip, and chip with measurement regions

A a chip and a method for producing the chip with a plurality of measurement regions which are provided with electrodes for electrically detecting reactions in which, in order to reliably separate the individual measurement regions from one another, a monolayer of a fluorosilane is formed on the chip surface which has strongly hydrophobic properties. Therefore, during spotting with a liquid, the drops of liquid applied by spotting can be reliably prevented from coalescing, and thus, causing mixing of the substances in the drops of liquid which are supposed to be immobilized in the measurement regions.. ... Boehringer Ingelheim Vetmedica Gmbh

02/25/16 / #20160051984

Device for controlling fluid flows in lab-on-a-chip systems

An array of valves are arranged in n columns and m lines and which are each designed to control a fluid flow in an associated flow channel in a lab-on-a-chip system. The array includes at least two valves, every column having not more than one valve and every line having from zero to n valves. ... Boehringer Ingelheim Vetmedica Gmbh

02/18/16 / #20160047832

System for operating a system for the integrated and automated analysis of dna or protein

A system for the integrated and automated analysis of dna or protein, including a single-use cartridge, with an analysis device having a control device, and devices for capturing and processing signals, the control device carrying out a completely automatic process and evaluation of molecular diagnostic analysis via single-use cartridges (lab-on-a-chip). Controlling of an analysis process, which occurs in the cartridge, involves the subsequent displacement and thermostatisation of liquids with a first device, and with a second device the signals which are obtained during the analysis are processed. ... Boehringer Ingelheim Vetmedica Gmbh

02/11/16 / #20160041193

Method for operating a system for the integrated and automated analysis of dna or protein

A method for the integrated and automated analysis of dna or protein, including a single-use cartridge, with an analysis device having a control device, and devices for capturing and processing signals, the control device carrying out a completely automatic process and evaluation of molecular diagnostic analysis via single-use cartridges (lab-on-a-chip). Controlling of an analysis process, which occurs in the cartridge, involve the subsequent displacement and thermostatisation of liquids with a first device, and with a second device the signals which are obtained during the analysis are processed. ... Boehringer Ingelheim Vetmedica Gmbh

02/11/16 / #20160040136

Novel prrs virus inducing type i interferon in susceptible cells

The present invention relates to the field of attenuated live viruses useful as vaccine or medicament for preventing or treating porcine reproductive and respiratory syndrome (prrs) in swine, and is based on the surprising finding of a prrs virus which is able to induce the interferon type i response of a cell infected by said virus. In one embodiment, the prrs virus according to the invention is a prrs virus mutant comprising, in comparison with the genome of a wild type strain, a mutation in the gene encoding the non structural protein 1 (nsp1) of said virus.. ... Boehringer Ingelheim Vetmedica Gmbh

02/04/16 / #20160030349

Nanoparticles, methods of preparation, and uses thereof

The present invention relates to core-shell nanoparticles, methods for their production, and their use, in particular as adjuvants. Generally, the nanoparticles of the invention comprise a solid core consisting of a biodegradable polymer and a shell of amphiphilic molecules disposed about said core.. ... Boehringer Ingelheim Vetmedica Gmbh

01/28/16 / #20160025667

Apparatus for the detection of liquids or substances from liquids

An apparatus for detecting liquids or substances from liquids in spatially separate reaction zones using a plug-in module or a chip card for rapid immunological tests, for example, with the help of a reading device. The liquids or substances from liquids are detected by a sensor array and on which at least one diaphragm is arranged. ... Boehringer Ingelheim Vetmedica Gmbh








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Boehringer Ingelheim Vetmedica Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boehringer Ingelheim Vetmedica Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###